Our option positions have a busy week ahead.

There are three events which could weigh in on the trading of our bearish food positions. We entered three new put positions last week in the following stocks:  Campbell Soup Company (NYSE: CPB), Kroger (NYSE: KR) and McCormick (NYSE: MKC).

Although each one has its unique bear story, they are all being pressured by industry trends. A shift in consumer preferences away from packaged foods and a deceleration in traffic at traditional grocery stores are squeezing earnings.

I’ll be listening to the management of Kroger and management teams of competing companies to hear about how demand and pricing are holding up in the food industry.

Feel free to listen using the information below to hear their commentary first-hand. Of course, if your schedule doesn’t make that possible I’ll be listening in and reporting back to you what I hear and what you should do in response.

• Tuesday, March 21 at 8:30 am (EST): General Mills (GIS) will report earnings before the market opens and host a conference call at 8:30 am (EST). The webcast can be accessed from the following link: http://investors.generalmills.com/Fiscal-2017-Third-quarter-Earnings-Results

• Tuesday, March 21 Kroger (NYSE: KR) will present at Telsey Advisors, a brokerage conference in NYC. The presentation isn’t broadcasted live, but I will be following live news feeds and will review the presentation transcript after it’s published.

• Thursday, March 23 Conagra (NYSE: CAG) will report third quarter earnings before the market opens and will host a conference call at 9:30 am (EST). You can access the webcast from the following link: http://www.conagrabrands.com/investor-relations/financial-news/events-calender

For investors still following Winnebago (NYSE: WGO), a stock whose put position expired last week; the company will be reporting earnings on Wednesday, March 22 with a conference call at 10 am (EST).  I’m not putting on a new put position but some subscribers have asked about rolling into a new series. If you choose to do so, you could think about the April puts with a strike of 28 or 29.

In news around the stock portfolio:

Despite the fact that GoPro’s (NSDQ: GPRO) influence over Ambarella’s (NSDQ: AMBA) numbers is fading, the stocks still trade in tandem. Ambarella jumped 6% last week when GoPro gave better than expected guidance for first quarter revenue in the first quarter. For those not following the live action disaster in GoPro’s stock, it has delivered disappointing results for the past 18 months due to product mishaps and poor sales. That trend seems to be reversing as the company made a surprise mid-quarter announcement that sales are tracking ahead of plan.

Jazz Pharmaceuticals (NSDQ: JAZZ) failed to respond to two positive events last week as the drug group was pulled down by disappointing news from leaders Amgen (NSDQ: AMGN) and Biogen (NSDQ: BIIB).

After meeting with CFO Matt Young, JPMorgan analyst Jessica Fye says Jazz Pharmaceuticals remains one of her favorite stocks and offers an attractive entry point. The analyst expects “healthy” sales and earnings growth in 2017 as well as new positive developments several of Jazz’s new drugs in trial.

The company also announced that it had enrolled the first patient in its Phase 3 clinical study evaluating JZP-258, an investigational oxybate product candidate as a potential treatment for cataplexy and excessive daytime sleepiness in adult narcolepsy patients. Phase 3 is the final phase of a drug study before approval.

I’ll be sure to post any updates from the conference calls mentioned above and will be watching our infrastructure puts closely as they are both hovering near their strike prices. This could signal a big gain on the horizon.  As always I’ll send along a trade alert for any new positions.  Enjoy the week.